West Pharmaceutical Profile

Performance

   

Odds of Distress

Fiscal Quarter End: December 31, 2019
Equity ratings for West Pharmaceutical Services are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting August 21, 2019 and ending today November 19, 2019. Click here to learn more.

West Pharmaceutical Profile

Next fiscal quarter end is expected on December 31, 2019. West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company was founded in 1923 and is headquartered in Exton, Pennsylvania. West Pharmaceutical operates under Medical Instruments Supplies classification in USA and is traded on BATS Exchange. It employs 7600 people. more
NameWest Pharmaceutical Services
CEOEric GreenView All
Thematic Classification
Currently Active Investing Idea
  Obamacare Repeal
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Healthcare Products
InstrumentUSA Stock View All
RegionNorth America
Business Address530 Herman O. West Drive, Exton, PA 19341-0645, United States
ExchangeBATS Exchange
CIK Number0000105770
ISINUS9553061055
SectorHealthcare
IndustryMedical Instruments & Supplies
BenchmarkDOW
Websitewww.westpharma.com
Phone610 594 2900
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterSeptember 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestOctober 15, 2019
West Pharmaceutical Services (WST) is traded on BATS Exchange in USA and employs 7,600 people. The company currently falls under 'Large-Cap' category with total capitalization of 10.99 B. West Pharmaceutical runs under Healthcare sector within Medical Instruments & Supplies industry. The entity has 73.99 M outstanding shares of which 595.7 K shares are at this time shorted by investors with about 1.56 days to cover shorted positions. WEST PHARMA SVCS has about 396 M in cash with 156.21 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.35.
Check West Pharmaceutical Probability Of Bankruptcy

Ownership Allocation (%)

West Pharmaceutical Target Price Odds Analysis

Odds Below 150.15HorizonTargetOdds Above 150.15
97.01%30 days 150.15 2.91%
Based on normal probability distribution, the odds of West Pharmaceutical to move above current price in 30 days from now is roughly 2.91 (This West Pharmaceutical Services probability density function shows the probability of West Pharmaceutical Stock to fall within a particular range of prices over 30 days) .

West Pharmaceutical Top Holders

West Pharmaceutical Services Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

West Pharmaceutical Key Fundamentals

West Pharmaceutical Against Markets

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

West Pharmaceutical Upcoming and Recent Events

West Pharmaceutical Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportFebruary 13, 2020
Next Earnings ReportApril 23, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndFebruary 13, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

West Pharmaceutical Corporate Filings

West Pharmaceutical SEC Reporting

Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
Unclassified Corporate Event
Entry into a Material Definitive Agreement
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

West Pharmaceutical Distributions to stockholders

West Pharmaceutical Corporate Directors

Mark Buthman Independent Director
Deborah Tanner Independent Director
John Weiland Independent Director
See also Your Current Watchlist. Please also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Search macroaxis.com